806 related articles for article (PubMed ID: 8162356)
1. New perspectives in vaccine development: mucosal immunity to infections.
McGhee JR; Kiyono H
Infect Agents Dis; 1993 Apr; 2(2):55-73. PubMed ID: 8162356
[TBL] [Abstract][Full Text] [Related]
2. New perspectives in mucosal immunity with emphasis on vaccine development.
McGhee JR; Fujihashi K; Xu-Amano J; Jackson RJ; Elson CO; Beagley KW; Kiyono H
Semin Hematol; 1993 Oct; 30(4 Suppl 4):3-12; discussion 13-5. PubMed ID: 8303308
[TBL] [Abstract][Full Text] [Related]
3. New generation of mucosal adjuvants for the induction of protective immunity.
Yuki Y; Kiyono H
Rev Med Virol; 2003; 13(5):293-310. PubMed ID: 12931340
[TBL] [Abstract][Full Text] [Related]
4. Mucosal immunity: regulation by helper T cells and a novel method for detection.
Jackson RJ; Marinaro M; VanCott JL; Yamamoto M; Okahashi N; Fujihashi K; Kiyono H; Chatfield SN; McGhee JR
J Biotechnol; 1996 Jan; 44(1-3):209-16. PubMed ID: 8717406
[TBL] [Abstract][Full Text] [Related]
5. Regulation of mucosal and systemic antibody responses by T helper cell subsets, macrophages, and derived cytokines following oral immunization with live recombinant Salmonella.
VanCott JL; Staats HF; Pascual DW; Roberts M; Chatfield SN; Yamamoto M; Coste M; Carter PB; Kiyono H; McGhee JR
J Immunol; 1996 Feb; 156(4):1504-14. PubMed ID: 8568254
[TBL] [Abstract][Full Text] [Related]
6. Regulation of mucosal immune responses by T lymphocytes: the effect of chronic CD4+ T cell deficiency on IgA synthesis.
Mega J; Fujihashi K; Kiyono H
Reg Immunol; 1992; 4(2):70-8. PubMed ID: 1354470
[TBL] [Abstract][Full Text] [Related]
7. Routes of immunization and antigen delivery systems for optimal mucosal immune responses in humans.
Mestecky J; Michalek SM; Moldoveanu Z; Russell MW
Behring Inst Mitt; 1997 Feb; (98):33-43. PubMed ID: 9382757
[TBL] [Abstract][Full Text] [Related]
8. In defense of mucosal surfaces. Development of novel vaccines for IgA responses protective at the portals of entry of microbial pathogens.
McGhee JR; Mestecky J
Infect Dis Clin North Am; 1990 Jun; 4(2):315-41. PubMed ID: 2189002
[TBL] [Abstract][Full Text] [Related]
9. Strategies for the induction of immune responses at mucosal surfaces making use of cholera toxin B subunit as immunogen, carrier, and adjuvant.
Holmgren J; Czerkinsky C; Lycke N; Svennerholm AM
Am J Trop Med Hyg; 1994; 50(5 Suppl):42-54. PubMed ID: 8203723
[TBL] [Abstract][Full Text] [Related]
10. Current status and potential application of ISCOMs in veterinary medicine.
Morein B; Hu KF; Abusugra I
Adv Drug Deliv Rev; 2004 Jun; 56(10):1367-82. PubMed ID: 15191787
[TBL] [Abstract][Full Text] [Related]
11. Deficiency of IL-5 receptor alpha-chain selectively influences the development of the common mucosal immune system independent IgA-producing B-1 cell in mucosa-associated tissues.
Hiroi T; Yanagita M; Iijima H; Iwatani K; Yoshida T; Takatsu K; Kiyono H
J Immunol; 1999 Jan; 162(2):821-8. PubMed ID: 9916704
[TBL] [Abstract][Full Text] [Related]
12. The anatomy of mucosal immune responses.
Garside P; Millington O; Smith KM
Ann N Y Acad Sci; 2004 Dec; 1029():9-15. PubMed ID: 15681738
[TBL] [Abstract][Full Text] [Related]
13. Induction of secretory immunity and memory at mucosal surfaces.
Brandtzaeg P
Vaccine; 2007 Jul; 25(30):5467-84. PubMed ID: 17227687
[TBL] [Abstract][Full Text] [Related]
14. Exploration of mucosal immunity in humans: relevance to vaccine development.
Czerkinsky C; Holmgren J
Cell Mol Biol (Noisy-le-grand); 1994; 40 Suppl 1():37-44. PubMed ID: 7950860
[TBL] [Abstract][Full Text] [Related]
15. Unique characteristics of lacrimal glands as a part of mucosal immune network: high frequency of IgA-committed B-1 cells and NK1.1+ alphabeta T cells.
Saitoh-Inagawa W; Hiroi T; Yanagita M; Iijima H; Uchio E; Ohno S; Aoki K; Kiyono H
Invest Ophthalmol Vis Sci; 2000 Jan; 41(1):138-44. PubMed ID: 10634613
[TBL] [Abstract][Full Text] [Related]
16. Regulator and effector functions of T-cell subsets in human Leishmania infections.
Kemp M
APMIS Suppl; 1997; 68():1-33. PubMed ID: 9063493
[TBL] [Abstract][Full Text] [Related]
17. Mucosal responses to parenteral and mucosal vaccines.
Kaul D; Ogra PL
Dev Biol Stand; 1998; 95():141-6. PubMed ID: 9855424
[TBL] [Abstract][Full Text] [Related]
18. Mucosal immunity: implications for vaccine development.
Holmgren J; Czerkinsky C; Lycke N; Svennerholm AM
Immunobiology; 1992 Feb; 184(2-3):157-79. PubMed ID: 1587541
[TBL] [Abstract][Full Text] [Related]
19. Secretory immunoglobulin A: from mucosal protection to vaccine development.
Corthésy B; Spertini F
Biol Chem; 1999 Nov; 380(11):1251-62. PubMed ID: 10614817
[TBL] [Abstract][Full Text] [Related]
20. [Humoral aspects of mucous membrane immunity--perspectives for the female genital tract].
Briese V
Zentralbl Gynakol; 1986; 108(21):1282-8. PubMed ID: 3544610
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]